<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04760392</url>
  </required_header>
  <id_info>
    <org_study_id>GoMob-in</org_study_id>
    <nct_id>NCT04760392</nct_id>
  </id_info>
  <brief_title>Goal-directed Mobilization of Medical Inpatients</brief_title>
  <acronym>GoMob-in</acronym>
  <official_title>Goal-directed Mobilization of Medical Inpatients (GoMob-in) - a Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Inselspital, Berne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Inselspital, Berne</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Immobilization in general internal medicine inpatients is a major contributor to morbidity&#xD;
      and mortality. Goal-directed mobilization (GDM) may improve mobility. The aim of this study&#xD;
      is to assess, if GDM increases physical activity (DEMMI score) during hospitalization and&#xD;
      improves quality of care until 3 months after hospitalization.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 13, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">January 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline of the DEMMI score</measure>
    <time_frame>Day 5±1</time_frame>
    <description>Change of the de Morton Mobility Index (DEMMI) score (range 0 to 100 with 0 indicating poor physical activity and 100 indicating a high level of independent physical activity) from baseline (at study inclusion), assessed by independent, blinded physiotherapist</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline of the DEMMI score</measure>
    <time_frame>Hospital discharge (max. day 14±1)</time_frame>
    <description>Change of the de Morton Mobility Index (DEMMI) score (range 0 to 100 with 0 indicating poor physical activity and 100 indicating a high level of independent physical activity) from baseline (at study inclusion), assessed by independent, blinded physiotherapist</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mobilization time</measure>
    <time_frame>During hospitalization (max. 14±1 days)</time_frame>
    <description>Mobilization time measured by accelerometer (i.e., time &quot;moving&quot; as total of time &quot;inactive&quot; and &quot;static&quot;, excluding time &quot;not worn&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of delirium episodes</measure>
    <time_frame>During hospitalization (max. 14±1 days)</time_frame>
    <description>As recorded in the discharge letter and nurse's protocol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of in-hospital falls</measure>
    <time_frame>During hospitalization (max. 14±1 days)</time_frame>
    <description>As recorded in the nurse's protocol (&quot;fall protocol&quot;)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length-of-hospital-stay</measure>
    <time_frame>3 months</time_frame>
    <description>Length-of-hospital-stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total number of falls (with / without injuries)</measure>
    <time_frame>3 months after study inclusion</time_frame>
    <description>By telephone interview with participant (if not available the patients next of kin or family doctor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of re-hospitalizations and all-cause mortality</measure>
    <time_frame>3 months after study inclusion</time_frame>
    <description>By telephone interview with participant (if not available the patients next of kin or family doctor)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Independence during activities of daily living: change in Barthel index between (German version)</measure>
    <time_frame>3 months after study inclusion</time_frame>
    <description>By telephone interview with participant</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concerns of falling: change in shor Falls Efficacy Scale - International (sFES-I, German version)</measure>
    <time_frame>3 months after study inclusion</time_frame>
    <description>Change (range 7 to 28 with 7 indicating no fear of falling and 28 indicating a high level of fear of falling) from baseline (at study inclusion), assessed by telephone interview with participant.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life: change in EuroQol (EQ-5D-5L, German version)</measure>
    <time_frame>3 months after study inclusion</time_frame>
    <description>Change (range from 0 to 100 with 0 indicating no problem and indicating 100 extreme problems) from baseline (at study inclusion), assessed by telephone interview with participant.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Immobility Syndrome</condition>
  <condition>Fall</condition>
  <condition>Delirium</condition>
  <condition>Sarcopenia</condition>
  <condition>Mobility Limitation</condition>
  <condition>Hospital Acquired Condition</condition>
  <arm_group>
    <arm_group_label>GDM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Goal-directed mobilization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard of care</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Goal-directed mobilization</intervention_name>
    <description>A short educational intervention with handout of a leaflet on GDM.&#xD;
Definition of personal mobility goal level.&#xD;
Communication of the mobility goal level to involved stakeholders.&#xD;
Regular reassessment of the mobility goal level and &quot;booster sessions&quot; by physiotherapists.</description>
    <arm_group_label>GDM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All consenting patients aged ≥ 18 years admitted to the Department of General Internal&#xD;
             Medicine, Inselspital, Bern University Hospital, Bern, Switzerland, who have an&#xD;
             indication for physiotherapy (prescription by the resident in charge or the care&#xD;
             coordinator).&#xD;
&#xD;
          -  Participants must be randomized at latest on the second day after hospital admission.&#xD;
&#xD;
          -  Written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to follow study procedures, i.e., due to language problems (unable to read,&#xD;
             speak or understand German), psychological disorders, severe dementia (defined as to&#xD;
             levels 5 - 7 in the Global Deterioration Scale), blindness, Patients unable to provide&#xD;
             informed consent themselves&#xD;
&#xD;
          -  Expected hospital stay for &lt; 5 days&#xD;
&#xD;
          -  Medically indicated bedrest for more than 24 h, e.g. after surgery&#xD;
&#xD;
          -  Injuries or neurologic deficits of one or both lower extremities directly impairing&#xD;
             walking capacity (e.g. fractures, hemiplegia, previous use of a wheelchair or&#xD;
             bedriddenness)&#xD;
&#xD;
          -  Terminal illness&#xD;
&#xD;
          -  Pregnancy or breast feeding&#xD;
&#xD;
          -  Previous enrolment in this study&#xD;
&#xD;
          -  A participant in the same patient room&#xD;
&#xD;
          -  Enrolment of the investigator, his/her family members, employees and other dependent&#xD;
             persons&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fabian D Liechti, MD-PhD, Dr. med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Inselspital, Bern University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Fabian D Liechti, MD-PhD, Dr. med.</last_name>
    <phone>+41 (0)31 632 21 11</phone>
    <phone_ext>181-7253</phone_ext>
    <email>fabian.liechti@insel.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>Inselspital, Bern University Hospital</name>
      <address>
        <city>Bern</city>
        <state>BE</state>
        <zip>CH-3010</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabian D Liechti, MD-PhD, Dr. med.</last_name>
      <phone>+41 (0)31 632 21 11</phone>
      <phone_ext>181-7253</phone_ext>
      <email>fabian.liechti@insel.ch</email>
    </contact>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>February 8, 2021</study_first_submitted>
  <study_first_submitted_qc>February 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
    <mesh_term>Sarcopenia</mesh_term>
    <mesh_term>Mobility Limitation</mesh_term>
    <mesh_term>Iatrogenic Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

